A61K36/66

Macrocyclic ligands with picolinate group(s), complexes thereof and also medical uses thereof

A macrocycle compound of general formula (X) ##STR00001##
in which Y.sub.1 represents a C(O)OH group or a group of formula (II) ##STR00002##

Macrocyclic ligands with picolinate group(s), complexes thereof and also medical uses thereof

A macrocycle compound of general formula (X) ##STR00001##
in which Y.sub.1 represents a C(O)OH group or a group of formula (II) ##STR00002##

USE OF PHARMACEUTICAL COMPOSITION IN PREPARING DRUG AGAINST HELICOBACTER PYLORI

A use of a pharmaceutical composition in preparing a drug against Helicobacter pylori. The pharmaceutical composition is suitable for oral administration and comprises a homogeneous mixture of edible oil, beeswax, and β-sitosterol. The beeswax in the composition forms microcrystals. Based on the total weight of the composition, the content of the beeswax is 0.5-50%, and the content of the β-sitosterol is 0.1-20%. The pharmaceutical composition can be used in inhibiting or killing Helicobacter pylori and in treating or preventing a disease caused by Helicobacter pylori.

USE OF PHARMACEUTICAL COMPOSITION IN PREPARING DRUG AGAINST HELICOBACTER PYLORI

A use of a pharmaceutical composition in preparing a drug against Helicobacter pylori. The pharmaceutical composition is suitable for oral administration and comprises a homogeneous mixture of edible oil, beeswax, and β-sitosterol. The beeswax in the composition forms microcrystals. Based on the total weight of the composition, the content of the beeswax is 0.5-50%, and the content of the β-sitosterol is 0.1-20%. The pharmaceutical composition can be used in inhibiting or killing Helicobacter pylori and in treating or preventing a disease caused by Helicobacter pylori.

USE OF PHARMACEUTICAL COMPOSITION IN PREPARING DRUG AGAINST HELICOBACTER PYLORI

A use of a pharmaceutical composition in preparing a drug against Helicobacter pylori. The pharmaceutical composition is suitable for oral administration and comprises a homogeneous mixture of edible oil, beeswax, and β-sitosterol. The beeswax in the composition forms microcrystals. Based on the total weight of the composition, the content of the beeswax is 0.5-50%, and the content of the β-sitosterol is 0.1-20%. The pharmaceutical composition can be used in inhibiting or killing Helicobacter pylori and in treating or preventing a disease caused by Helicobacter pylori.

Multifunctional traditional Chinese medicine health pillow
11000591 · 2021-05-11 ·

The present invention discloses a multifunctional traditional Chinese medicine health pillow. The health pillow is in an inverted concave shape; an outermost layer is a dense old coarse cloth sheet. The health pillow of the present invention not only treats cervical spondylosis, but also can activate blood circulation to dissipate blood stasis, reconcile yin and yang, regulate pulmonary function, regulate blood pressure and reduce blood lipid, treat insomnia, forgetfulness and neurasthenia, conduct effective hypnosis and sleep aid, and is more widely used in adjunctive therapy of cervical vertebra syndrome, scapulohumeral periarthritis, ankylosing spondylitis, lumbar muscle strain, lumbar vertebrae hyperplasia, lumbar disc herniation, sciatica, multiple peripheral neuritis, rheumatic fibrositis, atrophic lateral sclerosis, pain caused by bone degenerative change and pain caused by various soft tissue injuries.

Multifunctional traditional Chinese medicine health pillow
11000591 · 2021-05-11 ·

The present invention discloses a multifunctional traditional Chinese medicine health pillow. The health pillow is in an inverted concave shape; an outermost layer is a dense old coarse cloth sheet. The health pillow of the present invention not only treats cervical spondylosis, but also can activate blood circulation to dissipate blood stasis, reconcile yin and yang, regulate pulmonary function, regulate blood pressure and reduce blood lipid, treat insomnia, forgetfulness and neurasthenia, conduct effective hypnosis and sleep aid, and is more widely used in adjunctive therapy of cervical vertebra syndrome, scapulohumeral periarthritis, ankylosing spondylitis, lumbar muscle strain, lumbar vertebrae hyperplasia, lumbar disc herniation, sciatica, multiple peripheral neuritis, rheumatic fibrositis, atrophic lateral sclerosis, pain caused by bone degenerative change and pain caused by various soft tissue injuries.

Multifunctional traditional Chinese medicine health pillow
11000591 · 2021-05-11 ·

The present invention discloses a multifunctional traditional Chinese medicine health pillow. The health pillow is in an inverted concave shape; an outermost layer is a dense old coarse cloth sheet. The health pillow of the present invention not only treats cervical spondylosis, but also can activate blood circulation to dissipate blood stasis, reconcile yin and yang, regulate pulmonary function, regulate blood pressure and reduce blood lipid, treat insomnia, forgetfulness and neurasthenia, conduct effective hypnosis and sleep aid, and is more widely used in adjunctive therapy of cervical vertebra syndrome, scapulohumeral periarthritis, ankylosing spondylitis, lumbar muscle strain, lumbar vertebrae hyperplasia, lumbar disc herniation, sciatica, multiple peripheral neuritis, rheumatic fibrositis, atrophic lateral sclerosis, pain caused by bone degenerative change and pain caused by various soft tissue injuries.

ADVANCED GLYCATION END PRODUCT ANALOGUES
20210054012 · 2021-02-25 · ·

Disclosed are processes for the production of composition comprising one or more fructose amino acids, said process comprising the steps of: (a) providing plant material derived from a botanical source selected from plants of the families Solanaceae, Compositae, (Asteraceae), Guttiferae, Umbelliferae, Papaveraceae, Vitidaceae or Acanthaceae; (b) extracting one or more fructose amino acid(s) from said plant material; and optionally (c) detecting the presence and/or measuring the amount of said fructose amino acid(s) in the extract of step (b).

ADVANCED GLYCATION END PRODUCT ANALOGUES
20210054012 · 2021-02-25 · ·

Disclosed are processes for the production of composition comprising one or more fructose amino acids, said process comprising the steps of: (a) providing plant material derived from a botanical source selected from plants of the families Solanaceae, Compositae, (Asteraceae), Guttiferae, Umbelliferae, Papaveraceae, Vitidaceae or Acanthaceae; (b) extracting one or more fructose amino acid(s) from said plant material; and optionally (c) detecting the presence and/or measuring the amount of said fructose amino acid(s) in the extract of step (b).